We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
AngioDynamics
ANGO
$628M
| $465K | ﹤0.01% |
33,927
| – | – |
|
2252
Towne Bank
TOWN
$3.53B
| $465K | ﹤0.01% |
34,258
| – | – |
|
2253
UNIFI
UFI
$126M
| $465K | ﹤0.01% |
17,950
+600
| +3% | +$17K |
|
|
ORAN
2254
DELISTED
Orange
ORAN
| $464K | ﹤0.01% |
31,450
| – | – |
|
2255
German American Bancorp
GABC
$1.92B
| $461K | ﹤0.01% |
26,774
| – | – |
|
|
ALJ
2256
DELISTED
Alon USA Energy Inc
ALJ
| $461K | ﹤0.01% |
32,072
-1,050
| -3% | -$15.2K |
|
|
OWW
2257
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $461K | ﹤0.01% |
58,631
+100
| +0.2% | +$857 |
|
2258
Accuray
ARAY
$37.2M
| $460K | ﹤0.01% |
63,296
+900
| +1% | +$7.3K |
|
|
BKMU
2259
DELISTED
Bank Mutual Corp
BKMU
| $459K | ﹤0.01% |
71,559
| – | – |
|
2260
Alamo Group
ALG
$2.07B
| $458K | ﹤0.01% |
11,160
| – | – |
|
2261
W&T Offshore
WTI
$509M
| $458K | ﹤0.01% |
41,593
-110
| -0.3% | -$1.54K |
|
|
AVG
2262
DELISTED
AVG Technologies N.V.
AVG
| $458K | ﹤0.01% |
27,643
-1,000
| -3% | -$18.2K |
|
2263
CVR Energy
CVI
$3.35B
| $457K | ﹤0.01% |
10,223
+410
| +4% | +$19.7K |
|
2264
Medifast
MED
$145M
| $456K | ﹤0.01% |
13,878
-50
| -0.4% | -$1.53K |
|
|
NTRI
2265
DELISTED
NutriSystem, Inc.
NTRI
| $455K | ﹤0.01% |
29,593
+75
| +0.3% | +$1.25K |
|
2266
TriCo Bancshares
TCBK
$1.87B
| $453K | ﹤0.01% |
20,031
| – | – |
|
|
RTEC
2267
DELISTED
Rudolph Technologies Inc
RTEC
| $453K | ﹤0.01% |
50,006
+1,350
| +3% | +$12.9K |
|
2268
Usana Health Sciences
USNA
$421M
| $452K | ﹤0.01% |
12,278
+360
| +3% | +$13K |
|
|
MGI
2269
DELISTED
MoneyGram International, Inc. New
MGI
| $452K | ﹤0.01% |
36,074
| – | – |
|
|
KYTH
2270
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $452K | ﹤0.01% |
13,787
-350
| -2% | -$12.3K |
|
|
ELNK
2271
DELISTED
EarthLink Holdings Corp.
ELNK
| $451K | ﹤0.01% |
131,829
-6,600
| -5% | -$25.9K |
|
2272
Cohu
COHU
$2.5B
| $449K | ﹤0.01% |
37,491
| – | – |
|
2273
POSCO
PKX
$16.5B
| $449K | ﹤0.01% |
5,921
-600
| -9% | -$47.9K |
|
2274
Theravance Biopharma
TBPH
$875M
| $449K | ﹤0.01% |
19,474
-1,407
| -7% | -$40.8K |
|
2275
Banco Bradesco
BBD
$37.9B
| $448K | ﹤0.01% |
80,241
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.